Search research articles
Contact Us
Filters
Showing results (261-270 of 343) with videos related to
Page
of 35
Sort By:
NPJ Precision Oncology
|
July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Cancer
|
June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma
Jordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Cancer Discovery
|
February 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
BJU International
|
November 19, 2010
Early prostate cancer--which treatment do men prefer and why?
Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
Gastroenterology
|
March 6, 2019
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D Singhi, Ben George, Joel R Greenbowe, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
The Oncologist
|
February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers
Natalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Awalpreet S Chadha, Guan Liu, Hsiang-Chun Chen, et al.
Page
of 35
Search research articles
Search
Showing results (261-270 of 343) with videos related to
Sort By:
Page
of 35
NPJ Precision Oncology
|
July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Cancer
|
June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma
Jordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Cancer Discovery
|
February 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
BJU International
|
November 19, 2010
Early prostate cancer--which treatment do men prefer and why?
Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
Gastroenterology
|
March 6, 2019
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D Singhi, Ben George, Joel R Greenbowe, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
The Oncologist
|
February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers
Natalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Awalpreet S Chadha, Guan Liu, Hsiang-Chun Chen, et al.
Page
of 35